ASP Isotopes (ASPI) announced that the Company’s proposed offer to acquire all of the issued ordinary shares of JSE-listed Renergen Limited has been approved as of July 23, 2025, by the Competition Commission of South Africa, CC of South Africa, subject to certain conditions, which are acceptable to the Company. The implementation of the Scheme remains subject to and will only become operative upon the fulfilment or, if applicable, waiver of the outstanding conditions, including various regulatory approvals and third party consents, by no later than September 30, 2025, unless extended. If all remaining conditions are fulfilled or, if applicable, waived, the Scheme is expected to become effective in the third quarter of 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPI:
- ASP Isotopes prices 7.5M shares at $8.00 in registered direct offering
- Unusually active option classes on open July 17th
- ASP Isotopes announces updates on commercial production at enrichment facilities
- Renergen shareholders approve acquisition by ASP Isotopes
- ASP Isotopes appoints Ryno Pretorius as CEO, Quantum Leap Energy